ÿþvar listOfKeywords_de_DE = ["Aachen","Aachen Fachhochschule","Aachen Universität","Aachen Wirtschaft","Abschlussarbeit","Absolvent","action medeor","Akute Schmerzen","Alemannia Aachen","Allgemein","Analgetika","Analgetika Arten","Anreisekosten","Arbeitgeber","Arbeitsatmosphäre","Arbeitsplatz","Arten von Analgetika","Arthritisschmerzen","Arzneimittel","Arzneimittelabgabe","Arzneimittelmissbrauch","Arzneimittelspende","Assessment Center","Auf einen Blick","Ausbildung","Auszubildende","B1 Rezeptor","Bachelor","Behandlung akuter Schmerzen","Behandlung chronischer Schmerzen","Behandlung von Schmerzen","Beirat","Berufserfahrene","Berufserfahrung","Berufsfelder","Betriebssport","Beurteilung","Beurteilung von akuten Schmerzen ","Beurteilung von chronischen Schmerzen","Beurteilung von Schmerzen","Bewerbung","Bewertung","Bildung","Bonussystem","Bradykinin Rezeptor","CEO","Change Pain","Charta der Vielfalt","CHIO","Chronische Schmerzen","Colistin","Conceplan M","Contramal","Deutsche Gesellschaft für Palliativmedizin","Deutsche Hospiz-Gesellschaft","Diagnose","Diplomarbeit","Dom","DOR","Dr Stock","Dr. Harald Stock","Dr. Stock","EFIC-GRÜNENTHAL Grant","EHS Policy","Eifel","Einschätzung","Einschätzung von Schmerzen","Engagement","Entdecke Grünenthal","Entstehung von Schmerzen","Entwicklung","Entwicklung Analgetika","Entwicklung von Schmerzen","Erfahrung","Erfolg","erfolgreiches Unternehmen","Eric-Paul Paques","Eric-Paul Pâques","Eupen","Euregio","Europäischer Marktführer","Executive board","F&E","Fachhochschule Aachen","Familienbesitz","Fördern","Förderung","Forschung","Forschungs- und Entwicklungszentrum","Forschungspreis","Frauen Schmerz","Freiwillige Selbstkontrolle der Arzneimittelindustrie","Freizeit","FSA","Genten","Geschäftsführer","Geschäftsführung","Geschichte","Gesellschaft","Gewinn","Global Clinical Development","Globale Klinische Entwicklung","Grünenthal allgemein","Grünenthal Engagement","Grünenthal Geist","Grünenthal in Kürze","Grünenthal Stiftung","Harald F. Stock","Harald Stock","Heerlen","Hilfsmittel zur Schmerzbeurteilung","Hochschule Aachen","Hohes Venn","Hospizbewegung","Human Resources","Hydrogelpflaster","Infrastruktur Aachen","Innovationen","Innovativ","Innovative Analgetika","Innovatives Unternehmen","Interessen","International","Internationales Unternehmen","Internationalisierung","Internationalität","Interview","IT","Job","Karlspreis","Karriere","Karriere entdecken","KCNQ2/3","Klinische Entwicklung","Koanalgetika","Konditionen","Konzernleitung","Kooperationen","Kooperationsstärke","KOR","Kosten chronische Schmerzen","Kreuzschmerzen","Kultur","Lebensqualität Schmerzpatient","Lehre","Leistungsorientierung","Leitbild des Unternehmens","Lidocain","Lousberg","Lüttich","Maas-Rhein-Region","Maastricht","Management","Männer Schmerz","Marketing und Sales","Markt Kooperationen","Marktführer","Marktführer Europa","Masterarbeit","Masterstudiengang","Medifron Digital Biotech","Megacillin","Missbrauch","Missbrauchserschwerende Formulierung","Mitarbeiter","M-long","MOR","MOR-NRI","Multikulturell","Nationalpark Eifel","Natur","Naturreservat Hohes Venn","NCE","Nebenwirkung Schmerzmittel","Neo-Eunomin","Neuartige Analgetika","Neue Arzneimittelabgabesysteme","Neue Opioide","Neuropathische Schmerzen","Nicht-Opioide","Nicht-Opioid Analgetika","Norspan","Nozizeptive Schmerzen","Nozizeptoren","NRI","NTE","Nucynta","Öcher Bend","Opioid Buprenorphin","Opioid Rezeptoren","Opioidrezeptoren","ORL1","Osteoarthritis","Osteoarthrose","Osteoporoseschmerzen",

"pain education","Palexia","Palliativmedizin ","Paques","Pâques","Paracetamol","Partner","Partnerschaften","Pathophysiologie","Penicillin","Potential","Präklinische Forschung","Praktika","Praktikum","Produkte","Prof Paques","Prof. Dr. Eric-Paul Pâques","Promotion","Psychogener Schmerz","Reisekosten","Rekrutierung","Rifa","Rifinah","Route Charlemagne","Rursee","RWTH Aachen","Schmerz","Schmerz ausdrücken","Schmerz dokumentieren","Schmerz einschätzen","Schmerz Frauen","Schmerz in Worte fassen","Schmerz Männer","Schmerz messen","Schmerz zeigen","Schmerzarten","Schmerzbehandlung","Schmerzbeurteilung","Schmerzempfinden","Schmerzentstehung","Schmerzexperte","Schmerzforschung","Schmerzforschung unterstützen","Schmerzfrei","Schmerzfreiheit","Schmerzgedächtnis","Schmerzintensität","Schmerzlinderung","Schmerzmanagement","Schmerzmittel","Schmerzmittel Nebenwirkung","Schmerzpatient Arbeitsplatz","Schmerzrezeptoren","Schmerzsensor","Schmerzspezialist","Schmerzstimulus","Schmerztagebuch","Schmerztherapie","Schmerztyp","Schmerzverarbeitung","Schmerzzustand","Schmerzzustände","Schüler","Schwache Opioide","Selectomycin","Short-Term Incentive System (STI)","Somatische Schmerzen","Soziale Projekte","Soziale Verantwortung","Starke Opioide","Stefan Genten","Stiftung","Stock","Student","Studium","Studium Praxis","Stufenschema der Schmerztherapie","Supply Chain Management","Synphasec","Talent Management","Tamper Resistant Formulation","Tapentadol","Technische Universität","Technologieregion","Teilzeitarbeit","Telefoninterview","Therapie akuter Schmerzen","Therapie chronische Schmerzen","Therapie von Schmerzen","Tiergarten","Töchter","Tochtergesellschaften","Traineeprogramm","Tramadol","Tramal","Tramal Long","Transdermales Pflaster","Transient receptor potential vanilloid 1","Transtec","Transtec 35","Transtec 52.5","Transtec 70","TRF","TRPV1","Tumorschmerzen","Überblick","Umsatz","Umweltmanagementsystem","Umweltschutz","Universität Aachen","Unterstützung Schmerzforschung","Untersützung","Vanilloid Rezeptor","Vergütung","Versatis","Viszerale Schmerzen","Voraussetzungen","Vorstand","Vorstellungsgespräch","Was wir tun","Weiterbildung","Weltweit tätig","Wer wir sind","Werksstudent","Wider den tierischen Ernst","Wirtschaft","Würde","Zaldiar","Ziel Grünenthals","Zielvereinbarungssystem"];



var listOfKeywords_en_EN = ["Aachen","Aachen economy","Aachen university ","Aachen University of Applied Sciences","Acute pain","Advanced training","Advancement","Advisory board","Alemannia Aachen","Analgesics","Application","Apprenticeship","Arthritis pain","Assessment","Assessment center","At a glance","Bachelor's Courses of Study","Benefits","Bonus system","Bradykinin receptor","Cancer pain","Career","CEO","Change Pain","Charter of Diversity","Chief Executive Officer","Chief Financial Officer","Chief Operating Officer","CHIO","Chronic pain","Co-development","Colistin","Company sport","Compensation","Conditions","Cooperations","Corporate Executive Board","Costs chronic pain","Cultural influences","Culture","Death free from pain","Deutsche Hospiz-Gesellschaft","Deutsche Gesellschaft für Palliativmedizin","Development","Development of analgesics","Development of pain","Diagnosis","Diagnosis of pain","Dignity","Discover Grünenthal","Documenting pain","DOR","Dr Stock","Dr. Harald Stock","Dr. Stock","Drug delivery systems","Drug donation","Drugs crisis situations","Drugs remote areas","Economy","Education","EFIC-GRÜNENTHAL Grant","EHS Policy","Eifel","Employee","Employer","Engagement","Environment protection","Environmental management system","Eric-Paul Paques","Eric-Paul Pâques","Eupen","Euregio","European Federation of Chapters of the International Association for the Study of Pain","European Market Leader","Executive board","Experience","Expert in pain","Explore careers","Expressing pain","Family ownership","Family-owned","Foundation","Free from pain","Free of pain","Further education","General","Global","Global Clinical Development","Global Commercial Operations","Global Controlling","Global Finance","Global Industrial Operations & Supply Chain Management","Global player","Global Products","Graduate","Grünenthal aim","Grünenthal at a glance","Grünenthal engagement","Grünenthal Foundation","Grünenthal Spirit","Harald Stock","Harald F. Stock","Heerlen","History","Hohes Venn","Home market","Hospice movement","Human Resources","Hydrogel plaster","Infrastructre Aachen","Innovations","Innovative","Innovative analgesics","Innovative company","Interests","international","International Association for Hospice & Palliative Care","International Charlemagne Prize","International company","Internship","Interview","IT","Job","Job interview","Job pain sufferer","Join Grünenthal","KCNQ2/3","Kinds of analgesics","Kinds of pain","KOR","Leisure","Lidocain","Liège","Lousberg","Low back pain","Maastricht","Management","Managing board","Managing pain","Market Cooperations","Market leader","Marketing & Sales","Maas-Rhine-region","Master's Courses of Study","Measuring pain","Medal for Combating Deadly Seriousness","Medicated plaster","Medifron Digital Biotech","Meet our employees","Megacillin","Men pain","Misuse","MOR","MOR-NRI","Multicultural","Nature","Nature Reserve Hohes Venn-Eifel","Neuropathic pain","New analgesics","Nobligan","Nociceptive pain","Non-opioids","Norspan","Novel analgesics","Novel drug delivery system","Novel opioids","NRI","Nucynta","Numeric analogue scale","Objective agreement","Objective agreement system","Öcher Bend","Oecher Bend","Opioid Buprenorphin","Opioid receptors","ORL1","Osteoarthritis","Osteoarthrosis","Osteoporotic pain","Pain","Pain assessment","Pain assessment tool","Pain development","Pain diagnosis","Pain education","Pain killer","Pain level","Pain management","Pain measurement","Pain memory","Pain physiology","Pain processing","Pain rate","Pain receptor","Pain reduction","Pain relief","Pain relief ladder",

"Pain research","Pain scales","Pain sensor","Pain specialist","Pain sufferer job","Pain therapy","Pain treatment partner","Painfree","Palexia","Palliative care","Palliative Medicine Foundation","Paques","Pâques","Paracetamol","Partnering","Partnering meetings","Part-time employment","Patch","Pathophysiology","Penicillin","Personal contribution","Pharmaceutical","Polymer-Matrix","Portfolio late stage projects","Potential","Preserve quality of living","Prevent pain","Products","Prof Paques","Prof. Dr. Eric-Paul Pâques","Professional experience","Professional field","Professionals","Promotion","Psychogenic pain","Pupil","Quality of life","R&D","R&D Centre","Recruitment process","Requirements","Research","Research award","Rifa","Rifinah","Route Charlemagne","Rur lake","RWTH Aachen","Sales market","Selectomycin","Severe chronic pain","Short-Term Incentive System (STI)","Show pain","Side effect","Social influences","Social projects","Social responsibility","Society","Somatic pain","Sponsoring","Sports association","Stefan Genten","Stock","Strength in cooperation","Strong opioids","Student","Student trainee","Study","Study and practice","Subsidiary","Success","Successful company","Supply Chain Management","Support pain research","Affiliate","Talent Management","Tamper Resistant Formulation","Tapentadol","Target agreement","Technical university","Technology Region Aachen","Telephone interview","Therapy of acute pain","Therapy of chronic pain","Therapy of pain","Topalgic","Tradol","Trainee","Trainee program","Training","Tramadol","Tramadol hydrochloride","Tramal","Tramal Long","Tramal SR","Transdermal patch","Transient receptor","Transtec 35","Transtec 52.5","Transtec 70","Travel expenses","Treating chronic pain","Treatment","Treatment acute pain","Treatment chronic pain","Treatment of pain","TRF","TRPV1","Turnover","Types of analgesics","Types of pain","Ultram","University","University of Applied Sciences","University of technology","Vanilloid receptor","Versatis","Visceral pain","Vision mission","Visual analogue scale","Voltage-gated potassium channels","Voluntary self-regulation of the pharmaceutical industry","Weak opioids","What we do","Who we are","Women pain","Work environment","Working student","World leader","Worldwide active","Zaldiar","Zoo"];



var listOfKeywords_es_ES = ["10º Aniversario Fundacion Grunenthal","Acabel", "Acabel Rapid","Acciones solidarias","Administración de fármacos","Adolonta","Adolonta retard","Alivio del dolor","Alzheimer","Analgésico","Analgesico accion central","Analgésicos","Analgésicos no opiáceos","Aparición de dolor","Apoyo el Investigación de dolor","Axura","B1 Receptor","Beca EFIC","Calidad asistencial","Campaña change pain","Campaña evalualo","Canales de potasio","Carmen Ruiz","Catedra dolor","Cátedra dolor Cádiz","Cátedra dolor salamanca","Catedra economia de la salud","Catedra externa dolor","Catedra extraordinaria dolor","Catedra medicina de familia","Cátedra upf-semg-Grünenthal","Cátedras del dolor","Change Pain","Clemente Muriel ","Combinacion tramadol paracetamol","Comparar el dolor","Curso dolor geriatria","Curso nacional alzheimer","Curso pain","Curso urgencias traumatológicas","Cursos pain","Desarrollo del dolor","Diario del Dolor","Directores Grunenthal","Directrices de la OMS ","Dolor","Dolor agudo","Dolor crónico","Dolor cronico intenso","Dolor cronico moderado","Dolor hombres","Dolor intenso","Dolor lumbar","Dolor moderado","Dolor mujer","Dolor neuropático","Dolor nociceptivo","Dolor oncológico","Dolor por artritis","Dolor por osteoporosis ","Dolor psicogénico","Dolor severo","Dolor somático","Dolor visceral","Educacion medica continuada","EFIC","EFIC Grünenthal Grant","E-G-G","El dolor de la mujer","Elige Grünenthal","Empresa lider dolor","Escala de valoración numérica","Escala del dolor","Escala Visual Analógica ","Escalas del dolor","Escalera Analgésica","Espíritu de Grünenthal","Evaluación del dolor","Evaluación del dolor agudo","Evaluación del dolor crónico","Evalualo","Evaluar del dolor","Expedicion solidaria stop dolor","Expertos de dolor","Expresar el dolor","Expresión del dolor","Fomento de la investigacion","Formacion medica continuada","Formulacion con mecanismo de seguridad","Frecuentes de dolor","Fundación Grünenthal","Grünenthal en España","Grünenthal España","Grünenthal Pharma","Guia dolor","Guia sobre el dolor","Guillermo Castillo","Herramientas de valoración del dolor","Hombres dolor","I+D dolor","I+D Grünenthal","I+D preclínica","Ignacio Martínez","imagenes dolor","Intensidad del dolor","Investigación","Investigación de dolor","Investigación y Desarrollo","IRN","Isabel Sánchez","Joachim Teubner","Jörg Irouschek","Jornadas dolor y sociedad","José Manuel Massó","Karen Ticozzi","Klaus Wehmeier","Limitaciones tratamiento actual dolor","Logos Grünenthal","Luis F. Lozano","Medicamentos dolor","Medicamentos innovadores","Medinsa","Medioambiente","Medir el dolor","Memantina","Memoria del dolor","Migraña","No opioides","Nociceptores","Nuevos compuestos químicos","Nuevos sistemas de administración ","Opioides débiles","Opioides fuertes","Opioides nuevos","Organización Mundial de la Salud","Paracetamol","Parche buprenorfina","Parche dolor","Parche transdérmico","Patronato","Planta de fabricación ","Plataforma SinDOLOR","Play4Africa","Premio de periodismo","Premio investigacion Fundacion Grünenthal","Premio investigacion Grunenthal","Premio periodismo","Premio periodismo plataforma SinDOLOR","Premios a la investigacion","Premios investigacion dolor",

"Premios periodismo dolor","Prevenir el dolor","Procesar el dolor","Productos contra el dolor","Productos farmacéuticos dolor","Proyectos de investigacion dolor","Publicaciones dolor","RDO","Receptor 1 de la bradicinina","Receptor bradicinina","Receptor vanilloide","Receptores de los opiáceos","Receptores del dolor","Receptores nociceptivos","Referente tratamiento dolor","Registrar el dolor","Registro del dolor","Responsabilidad social","Responsabilidad Social Corporativa ","Respuesta del dolor ","Reunion de expertos salamanca","Reunion expertos universidad salamanca","RKO","RMO","Rosa Moreno","Ruta stop dolor","Sensibilidad al dolor","Sensores del dolor","Siente Grünenthal","SRO1","Stop Dolor","Tamper Resistant Formulation","Tapentadol","Tipo del dolor","Tipos de dolor","Tipos del analgésicos","Tipos del dolor","Todo sobre el dolor","Trabajar en Grünenthal","Trabajo en Grünenthal","Tramadol","Transtec","Tratamiento alzheimer","Tratamiento del dolor","Tratamiento del dolor","Tratamiento del dolor agudo ","Tratamiento del dolor crónico","Tratamiento dolor","Tratamiento migraña","Tratamiento sintomático dolor moderado","Tratar el dolor","TRF","Universidad de Cádiz ","Universidad de Salamanca","Universidad Pompeu-Fabra ","Valle Riera","valoración del dolor","Versatis","Víctor Barbosa","Zaldiar","Zaldiar Efervescente","Zomig"];



var listOfKeywords_da_DK = ["Aachen","akut smerte","akut smertebehandling","arbejdsmiljø","behandling","behandling af akutte smerter","behandling af kroniske smerter","bestyrelse","bidrag","bivirkning","CEO","Change Pain","Dr Stock","Dr. Harald Stock","Dr. Stock","erfaring","Europæisk markedsleder","familieejet","førende på det europæiske marked","forskning","forskningsbaseret","global","globale produkter","grundlagt","Harald Stock","Harald F. Stock","Historie","Industrielle samarbejder","innovation","Innovative","innovative smertestillende lægemidler","international","international virksomhed","internationalisering","job","karriere","karriere hos Grünenthal","kronisk smertebehandling","Kroniske smerter","livskvalitet","måle smerte","markedsføring","markedsleder","medarbejder","medicinal","nye smertestillende lægemidler","Om os","omsætning","økonomi","partner inden for smertebehandling","partnerskaber","Penicillin","produkter","samarbejder","smerte","smertebehandling","smerteekspert","smerteforskning","Smertelindrende","smertelindring","Smertestillende","smertestillende lægemidler","støtte","succes","succesfuld virksomhed","svære kroniske smerter","talentudvikling","træning","typer af smerter","udvikling","udvikling af smerte","udvikling af smertestillende lægemidler","Universitet"];



var listOfKeywords_fr_BE = ["Aachen","Aachen economy","Aachen university ","Aachen University of Applied Sciences ","Aachen University of Applied Sciences ","acute pain","Adolonta","advanced training","advancement","advisory board","Alemannia Aachen","Amoxypen","analgesics","application","apprenticeship","arthritis pain","assessment","assessment center","at a glance","Bachelor's Courses of Study","Balanca","Belara","benefits","bonus system","bradykinin receptor","cancer pain","career","CEO","Change Pain","Charter of Diversity","Chief Executive Officer","Chief Financial Officer","Chief Operating Officer","CHIO","chronic pain","co-analgesic","co-development","Colistin","company sport","compensation","Conceplan M","conditions","Contramal","cooperations","Corporate Executive Board","costs chronic pain","cultural influences","culture","death free from pain","Desmin","Deutsche Hospiz-Gesellschaft","Deutsche Gesellschaft für Palliativmedizin","development","development of analgesics","development of pain","diagnosis","diagnosis of pain","dignity","discover Grünenthal","documenting pain","DOR","Dr Stock","Dr. Harald Stock","Dr. Stock","drug delivery systems","drug donation","drugs crisis situations","drugs remote areas","economy","education","EFIC-GRÜNENTHAL Grant","EHS Policy","Eifel","employee","employer","engagement","environment protection","environmental management system","environmentalism","Eric-Paul Paques","Eric-Paul Pâques","Eupen","Euregio","European Federation of Chapters of the International Association for the Study of Pain","European Market Leader","Eve 20","executive board","experience","expert in pain","explore careers","expressing pain","family ownership","family-owned","foundation","free from pain","free of pain","freedom of pain","further education","general","global","Global Clinical Development","Global Commercial Operations","Global Controlling","Global Finance","Global Industrial Operations & Supply Chain Management","global player","Global Products","graduate","Grüncef","Grünenthal aim","Grünenthal at a glance","Grünenthal engagement","Grünenthal Foundation","Grünenthal generally","Grünenthal in general","Grünenthal in short","Grünenthal Spirit","Harald Stock","Harald F. Stock","Heerlen","history","Hohes Venn","home market","hospice movement","Human Resources","hydrogel plaster","infrastructre Aachen","innovations","innovative","innovative analgesics","innovative company","interests","international","International Association for Hospice & Palliative Care","International Charlemagne Prize","international company","Internationalisation","internship","interview","IT","Jellin","Jelliproct","job","job interview","job pain sufferer","join Grünenthal","KCNQ2/3","kinds of analgesics","kinds of pain","KOR","leisure","Lidocain","Liège","Lousberg","low back pain","Maastricht","management","managing board","managing pain","market Cooperations","market leader","Marketing & Sales","Maas-Rhine-region","Master's Courses of Study","measurement tools","measuring pain","Medal for Combating Deadly Seriousness","medicated plaster","Medifron Digital Biotech","meet our people","Megacillin","men pain","misuse","M-Long","MOR","MOR-NRI","multicultural","national park Eifel","nature","Nature Reserve Hohes Venn-Eifel","Neo-Eunomin","neuropathic pain","new analgesics","Nobligan","nociceptive pain","non-opioids","Norspan","novel analgesics","novel drug delivery system","novel opioids","NRI","Nucynta","numeric analogue scale","objective agreement","objective agreement system","Öcher Bend","Oecher Bend","Opioid Buprenorphin","opioid receptors","ORL1","osteoarthritis","osteoarthrosis","osteoporotic pain","pain","pain assessment","pain assessment tool","pain development","pain diagnosis","pain education","pain killer","pain killer market","pain killer side effect","pain level","pain management","pain measurement","pain memory","pain physiology","pain processing","pain rate","pain receptor","pain reduction","pain relief","pain relief ladder",

"pain research","pain scales","pain sensor","pain sufferer job","pain therapy","pain treatment partner","painfree","Palexia","palliative care","Palliative Medicine Foundation","Paques","Pâques","paracetamol","partnering","partnering meetings","part-time employment","patch","pathophysiology","Penicillin","personal contribution","pharmaceutical","polymer-Matrix","portfolio late stage projects","potential","preserve quality of living","prevent pain","products","Prof Paques","Prof. Dr. Eric-Paul Pâques","professional experience","professional field","professionally experienced","professionals","promotion","psychogenic pain","pupil","quality of life","R&D","R&D Centre","R&D Internet Presence","recruitment process","requirements","research","research award","Rifa","Rifa Parenteral","Rifater","Rifinah","Route Charlemagne","Rur lake","RWTH Aachen","sales market","Selectomycin","severe chronic pain","Short-Term Incentive System (STI)","show pain","side effect","social influences","social projects","social responsibility","society","somatic pain","Spizef","sponsoring","sports association","Stefan Genten","Stock","strength in cooperation","strong opioids","student","student trainee","study","study and practice","subsidiary","success","successful company","Supply Chain Management","support pain research","Supratonin","Supraviran","Synphasec","Talent Management","Tamper Resistent Formulation","tapentadol","target agreement","technical university","Technology Region Aachen","telephone interview","therapy of acute pain","therapy of chronic pain","therapy of pain","Topalgic","Topsym","Tradol","trainee","trainee program","traineeprogramme","training","tramadol","tramadol hydrochloride","Tramal","Tramal Long","Tramal SR","transdermal patch","transient receptor","Transtec 35","Transtec 52.5","Transtec 70","travel expenses","treating chronic pain","treatment","treatment acute pain","treatment chronic pain","treatment of pain","TRF","TRPV1","turnover","types of analgesics","types of pain","Ultram","University","University of Applied Sciences","university of technology","vanilloid receptor","Versatis","visceral pain","vision mission","visual analogue scale","voltage-gated potassium channels","voluntary self-regulation of the pharmaceutical industry","weak opioids","what we do","who we are","women pain","work environment","working student","world leader","worldwide active","Zaldiar","zoo","Zydol"];



var listOfKeywords_nl_BE = ["actie medeor","acute pijn","analgetica", "pijnstillers","sollicitatie","arthritis","Met één oogopslag","carrière","CEO","Change Pain","chronische pijn","co-analgetica","Contramal","ontwikkeling","ontwikkeling van analgetica/pijnstillers","ontwikkeling van pijn","diagnose","diagnose van pijn","ontdek Grünenthal","pijn documenteren","Dr Stock","Dr. Harald Stock","Dr. Stock","Geneesmiddelendonatie","geneesmiddelen crisissituaties","opleiding","EFIC-GRÜNENTHAL Grant ","EHS-beleid","werknemer","werkgever","bescherming milieu","European Federation of Chapters of the International Association for the Study of Pain","expert in pijn","ervaring","ontdek carriëres","uitdrukken van pijn","familiebedrijf","zonder pijn","pijnvrij","vrijheid van pijn","algemeen","globaal","globale speler","Grünenthal doel","Grünenthal in één oogopslag","Grünenthal ","Grünenthal Foundation","Grünenthal algemeen","Grünenthal in het algemeen","Grünenthal in het kort","de geest van Grünenthal","Harald F. Stock","Harald Stock","geschiedenis","Human Resources","hydrogelpleister","vernieuwingen/innovaties","innoverend","innoverende analgetica","innoverend bedrijf","internationaal","interesses","international bedrijf","job","Kom bij ons werken","types analgetica/pijnstillers","types pijn","llage rugpijn","lidocaïne","management","pijn beheren","marktleider","meetinstrumenten","pijn meten","medicinale pleister","maak kennis met onze mensen","mannen pijn","neuropathische pijn","nociceptieve pijn","nieuwe analgetica","niet-opioïden","nieuwe analgetica","nieuw toedieningssysteem voor geneesmiddelen","nieuwe opioïden","numerieke analoge schaal","opioïd buprenorfine","opioïdreceptoren","osteoarthritis - artrose","osteoarthrose","osteoporotische pijn","pijn","pijnbeoordeling","pijnbeoordelingsmethodes","pijnontwikkeling","pijndiagnose","pain education","pijnstiller","pijnstillermarkt","pijnstiller bijwerking","pijnniveau","pijnmanagement","pijnmeting","pijngeheugen","pijnfysiologie","pijnverwerking","pijnscore","pijnreceptor","pijnvermindering","pijnverlichting","pijnverlichtingsladder","pijschalen","pijnonderzoek","pijntherapie","partner in pijnbehandeling","pijnvrij","Palexia","palliatieve zorg","paracetamol","pleister","pathofysiologie","farmaceutisch","polymeer-matrix","potentieel","levenskwaliteit behouden","pijn voorkomen","producten","professionele ervaring","psychogenic pain","levenskwaliteit","R&D","onderzoek","onderzoeksbeurs","ernstige pijnmarkt","pijn tonen","bijwerking","somatische pijn","Stock","sterke opioïden","succes","succesvol bedrijf","Tamper Resistent Formulation","tapentadol ","therapie voor acute pijn","therapie voor chronische pijn","therapie voor pijn","training","tramadol","tramadol hydrochloride","Contramal","Contramal Retard","Contramal UNO","transdermale pleister","Transtec","Transtec® 35 ¼g/h","Transtec® 52.5 ¼g/h","Transtec® 70 ¼g/h","chronische pijn behandelen","behandeling","behandeling acute pijn","behandeling chronische pijn","pijnbehandeling","TRF","types analgetica/pijnstillers","types pijn","Versatis","viscerale pijn","visueel analoge schaal VAS","visie missie","spanningsafhankelijke kaliumkanalen","zwakke opioïden","wat doen wij","wie zijn wij","vrouwen pijn","werkomgeving","wereldleider","wereldwijd actief","Zaldiar"];



var listOfKeywords_nl_NL = ["2009","2010","Actuele persberichten","Acute pijn","Afbeeldingen","Algemeen Directeur", "Alles over pijn","Amerika","Australië","Azië", "Bedrijfsinformatie","Bedrijfsfactsheets","Behandelingen","Beoordeling","Beoordeling en hulp","Beperking","Beperkingen van de huidige therapie","Boot","CEO","Change Pain","Chronische gewrichtsaandoening","Chronische pijn","Colistin®","Colistin® Patiëntenbijsluiter","Compliance","Contact","Contact en routebeschrijving","Corporate Executive Board","Culturele diversiteit","Danny Boot","De ontwikkeling","diagnoses","Directeur","Disclaimer","Download","Download afbeeldingen","Download Bedrijf","Download Informatiemateriaal","Download logo","download management team","Download Producten","Download Productie","Dr. Roberto Jongejan","Driesse","EFIC","EFIC-Grünenthal Grant","EGG","Europa","Feiten & Cijfers","Filiale Australië","Filialen Amerika","Filialen Azië","Filialen Europa","Filialen wereldwijd","Financieel Manager","Gearchiveerde persberichten ","Gender-verschillen in pijn","Geschiedenis","Gewrichtsaandoening","Grünenthal B.V.","Harald F. Stock","Hormonen","Hulp","Impressum","Info materiaal","Initiatief","Initiatieven","Innovatief","Internationaal","Jongejan","Lage rugpijn","Logo","Management Team","Manager","Mannen of vrouwen","Medewerkers","Meten en vergelijken","Michel Driesse","Nederland","Neuropathische pijn","Nieuws","Nieuws en persberichten","Nociceptieve pijn","Ondersteuning","Ondersteuning van de medewerkers","Ontmoet de medewerkers","Ontwikkeling","Onze missie","Over Grünenthal","Partnership","Pathofysiologie en Aandoeningen","Patiënten","Patiëntenbijsluiter","Patiëntenbijsluiter Colistin®","Patiëntenbijsluiter Seractil®","Patiëntenbijsluiter Tramal®","Patiëntenbijsluiter Transtec®","Pers","Persberichten","Perscentrum","Persinformatie","Persmateriaal","Pijn","Pijn mannen","Pijn meten","Pijn uitdrukken","Pijn vergelijken","Pijn vrouwen","Pijnbestrijding","Pijnbestrijdingsladder","Pijnsensoren","Privacyverklaring","Producten","Productie","Psychogene pijn","Psychologische factoren","R&D","Registratietekst","Research & development","Research in pijn","Richtlijn","Roberto Jongejan","Routebeschrijving","Seractil®","Seractil®  Patiëntenbijsluiter","Sfeer bij Grünenthal","Sociale betrokkenheid","Sociale en culturele Invloeden","Sociale factoren","Sollicitatie","Sollicitatiebrief","Soorten pijn","Stock","Succesvol","Team","Thalidomide","Tramal®","Tramal® Patiëntenbijsluiter","Transtec®","Transtec® patiëntenbijsluiter","Vacatures","Visie en Missie","Wat we doen","Werk & Carrière","WHO pijnbestrijdingsladder","WHO-richtlijn","Wij leiden op","Wijdverbreide aandoening","Zaldiar®"];



var listOfKeywords_de_AT = ["Aachen","Akuter Schmerz","Analgetika","Bewerbung","Matrifen","Tumorschmerzen","Karriere","Change Pain","Chronische Schmerzen","Colestin","Contramal retard","Entwicklung","Diagnose","EFIC-GRÜNENTHAL Grant","Engagement","European Federation of Chapters of the International Association for the Study of Pain","Erfahrung","Schmerzexperte","Schmerzerleben","Gründung","Grünenthal Gruppe","Geschichte","Innovation","Innovativ","International","Job","Lidocain","Management","MOR","Nicht-Opioide","Opioide","Schmerz","Paracetamol","Penicillin","Produkte","Psychogener Schmerz","Schwere chronische Schmerzen","Nebenwirkungen","Transtec 35 ¼g/h","Transtec 52.5 ¼g/h","Transtec 70 ¼g/h","Versatis","Zaldiar","Unternehmen","Transtec","Geschäftsführung","Medizin","Medical Scientific Liaison Manager","Marketing","Vertrieb","Finanzen","Verwaltung","Notfall","Gesundheitswesen","Verantwortung","Pain Award","Österreichischer Journalistenpreis Schmerz","EGG","EFIC","Österreichischen Schmerzgesellschaft","ÖSG","Deutschen Gesellschaft für Schmerztherapie","PAIN EDUCATION","Schmerzlinderung","P.A.I.N.","Miranax","Proxen","Proxen Saft","Tramal","Infektiologie","Fachinformationen","Viszeraler Schmerz","Somatischer Schmerz","Neuropathischer Schmerz","Schmerzentstehung","Schmerzwahrnehmung","Schmerzcharakter","Schmerzfragebogen","Schmerztagebuch","WHO","Co-Analgetika","Schmerzpflaster","Physiotherapie","Alternative Heilmethoden","Psychotherapie","Invasive Methoden","Unternehmensbroschüre"];



var listOfKeywords_en_UK = ["Aachen","Family ownership","Analgesia","Expertise","Grünenthal UK", "Sales","Marketing","Market access","medical science liaison team","Pain management","Chronic pain","Pain therapy","Acute pain","Tramacet","Non-opioid","Paracetamol","Opioid","Tramadol","Moderate pain","Severe pain","Versatis","Lidocain","Plaster","Herpes zoster infection","Postherpetic neuralgia","Zydol","Tramadol hydrochloride","Research & Development","Innovative","International","Patients","Healthcare Professionals","Nociceptive pain","Neuropathic pain","European Federation of the International Association of the Study of Pain chapters","EFIC","Values","Vision","Recruitment"];



var listOfKeywords_de_CH = ["Aachen", "Abgabesysteme", "Abhängigkeit", "Aktivität der Schmerzsensoren - Akutschmerz", "Aktuelle Informationen", "Akupunktur", "Akute Schmerzen", "Alarmfunktion von Schmerz", "Alles über Schmerz", "Analgesie", "Analgetika", "Antagonisten", "Antibiotika", "API Lieferant", "Arzneimittelabgabesysteme", "Arzneimittelabgabetechnologien", "Arzneimittelspenden", "Auswirkungen chronischer Schmerzen", "B1 Rezeptor", "Behandlung", "Behandlung chronischer Schmerzen", "Behandlung von Akutschmerz", "Behandlung von Schmerzen", "Belastung", "bestimmungsgemäßer Gebrauch", "Beurteilung und Hilfe - Akutschmerz", "Bewältigungsstrategien", "Bradykinin Rezeptor", "Change Pain", "CHANGE-PAIN-Initiative", "Chronifizierung der Schmerzen", "chronische Erkrankungen mit entzündlichem Hintergrund", "Chronische Gelenkerkrankung", "Chronische Schmerzen", "Clavamox", "Colistin", "Compliance", "Darreichungsformen", "degenerative Arthritis", "degenerative Gelenkerkrankung", "Dermatika", "Deutschland", "Diagnose von Akutschmerz", "Diagnose von chronischen Schmerzen", "Die Plattform für Schweizer Patientenorganisationen", "Distribution", "dynamisch", "EFIC", "EFIC-Grünenthal Grant", "EGG", "E-G-G", "Einklang mit Vorgaben", "Empfindlichkeit", "Endorphine", "Engagement", "Engagement gegen den Schmerz", "Engagement in verschiedene Richtungen", "Entwicklung", "Entwicklung neuer Opioide", "Entwicklungsprojekte", "entzündliche Erkrankungen", "Erforschung", "Erkenntnisse", "Erläuterung Akutschmerz", "Erscheinungsformen von Schmerz", "Erzeugnisse", "Europäische Schmerzgesellschaft", "F&E", "F&E-Zentrum", "Familienbesitz", "Fertigungsstätten", "Fokus: Behandlung von Schmerzen", "Fokussierung", "Förderung", "Formen von Schmerz", "Forschung und Entwicklung", "Forschungs- und Entwicklungszentrum", "Forschungspreis", "Fortbildung", "führende Rolle", "Gefahren klassischer Opioide", "Gefühl", "Gelenkschmerz", "gemeinsame Entwicklungen", "Gerhard H. Müller-Schwefe", "Geschichte", "Gesetzgebung", "Giustino Varrassi", "Global Clinical Development", "Globale Präklinik F&E", "Golden Supplier Award", "G-Protein", "Grenzen der heutigen Therapie", "Grundsätze", "Grünenthal", "Grünenthal GmbH", "Grünenthal Gruppe Schweiz", "Grünenthal Konzern", "Grünenthal Pharma AG", "Grünenthal Pharma AG Schweiz", "halb-feste Arzneimittel", "Hämorrhagien", "Hauptsitz", "Herausforderungen", "Herz des Unternehmens", "Hilfsmittel zur Schmerzbeurteilung", "Historie", "Hypnose", "in Worte fassen", "Infektiologie", "Infektionen", "Innovation", "innovative Forschung", "innovative Präparate", "Inovative Darreichungsformen", "Integrität", "international", "internationale Kooperationen", "Irene Tracey", "Jeder Mensch kennt Schmerzen", "Jobservice Jobangebote", "junge Forscher", "Kaliumkanäle", "Kanalöffner", "KCNQ Kanalöffner", "KCNQ2/3", "Kernkompetenzen", "kombinierte Wirkmechanismen", "Kompetenz", "Kompetenzzentrum", "Kontrolle", "Kooperationsstärke", "KOR", "Körperschäden", "kosteneffizient", "Kreuzschmerzen", "Langfristig Schmerzforschung fördern", "Lebensqualität", "Linderung", "Management", "Mediatoren", "Medifron Digital Biotech", "Medikamente", "Missbrauch von Opioiden", "Missbrauchserschwerende Formulierung", "Mit Leidenschaft gegen den Schmerz", "Moderne Organisationsformen", "MOR", "Morphin", "NCEs", "NCEs zur Schmerzbehandlung", "Nebenwirkungen","Nebenwirkungsprofile verbessern","neuartige Analgetika", "neuartige Wirkstoffe", "Neue Arzneimittelabgabesysteme", 

"neue Medikamente", "neuropathisch", "neuropathische Schmerzen", "Nozizeptive Schmerzen", "Nozizeptoren", "NRI", "Operationen", "Opioide", "Opioidrezeptoren", "Optimierung der Schmerztherapie", "ORL 1", "Osteoarthritis", "Osteoarthrose", "Palette hochwirksamer Medikamente", "Palliativmedizin", "Paracetamol Grünenthal", "Partnerschaften", "Pathophysiologie", "Patienteninformationen", "Patientenorganisationen", "Penicillin", "Penicillin G", "Pharma", "Pharmakologie", "Pharmakonzern", "Präklinische Forschung und Entwicklung", "Preisverleihung", "Presse", "Pressekontakt", "Pressemeldungen", "Pressemitteilungen", "Produktbereich", "Produkte", "Produktion", "Produktionsstandorte", "Produktionszentrum", "Produktportfolio", "Proto Chemicals", "Proto Chemicals AG", "Protopharm", "Protopharm AG", "Proxen", "psychische und soziale Faktoren", "Psychogener Schmerz", "psychosoziale Faktoren", "Qualifikation", "Qualität", "Reflexe", "regional", "Richtlinien", "Röntgenbilder", "Rückenschmerzen", "Ruf des Unternehmens", "Schaltstelle unterschiedlicher Schmerzreize", "Schlüsseldaten", "Schmerz", "Schmerz - Eine eigenständige Krankheit", "Schmerz in Worte fassen", "Schmerzarten", "Schmerzbehandlung", "Schmerzbekämpfung", "Schmerzempfinden", "Schmerzen", "Schmerzforschung", "Schmerzforschungsprojekte", "Schmerzgedächtnis", "Schmerzlinderung", "Schmerzmittel", "Schmerzpflaster", "Schmerzstimulus",  "Schmerztherapie", "Schmerzwahrnehmung", "Schmerz-Werkzeugkoffer", "Schmerzzustände", "Schweiz", "Schweizer Rheumaliga", "Schweizerische Gesellschaft für Muskelkranke", "Schweizerische Kopfwehgesellschaft", "Schweizerische Krebsliga", "Schweizerische Patientenorganisation", "Schweizerische Polyathritiker Vereinigung", "Schweizerische Vereinigung gegen die Osteoporose", "Schweizerische Vereinigung Morbus Bechterew", "Schweizerischer Fibromyalgie Vereinigung", "seelische Probleme", "Selbsthilfegruppen und Verbände", "Sensibilitätsstörungen", "Somatosensorik", "Soziale und kulturelle Einflüsse", "Soziale Verantwortung", "Spannungsabhängige Kaliumkanäle", "Spenden", "Spezifizierungen", "Spitex Verband", "Sportverletzungen", "SPV", "Stabilität der Tabletten", "Standorte", "Stiftung Kosch", "Stoffwechselstörungen", "Struktur", "Stufenschema der Schmerztherapie", "Suchtgefahr", "Suppositorien", "Supracyclin", "SVGO", "Swiss Migraine Action", "Tamper Resistant Formulation", "Technologien", "Teil der Gesellschaft", "TENS", "Testosteron", "Toleranzentwicklung", "Tramal", "Tramal Hydrochlorid", "Tramal retard", "Transtec", "TRF", "TRPV 1", "Tumore", "Über Schmerz", "Überempfindlichkeit als Erkennungsmerkmal", "Unser Ziel", "Unsere Kooperationsstärke", "Unsere Produkte", "Unterdrückung chronischer Schmerzen", "Unternehmen", "Unternehmensgeschichte", "Unternehmensstruktur", "Unterschied im Schmerzempfinden zwischen Männern und Frauen", "Vanilloid-Rezeptor", "Verantwortung", "verbesserte Wirksamkeit", "Verbesserung der Medikamente", "Verbesserung von Schmerztherapien", "Vereinigung Schweizer Schmerzpatienten", "Verletzungen", "Verschiedene Behandlungsmöglichkeiten - Akutschmerz", "Vision", "viszerale Schmerzen", "Volkskrankheit Rückenschmerz", "Vorreiter in der Schmerzbekämpfung", "Vorschriften", "VSP", "Warnsignale", "Wegbereiter", "Weltgesundheitsorganisation", "Weltweiter Vorreiter", "weltweites Engagement", "Wer wir sind", "wettbewerbsfähig", "WHO", "WHO-Richtlinien für die Schmerzbehandlung", "Wirkstoffe", "Wirkstoff-Produktionsstätte", "Wissenswertes zum Schmerz", "Wo Wirkstoffe entstehen", "Zaldiar", "Zentrales Nervensystem", "Ziele","Zusammen erfolgreich","Zuverlässigkeit"];



var listOfKeywords_fr_FR = ["Laboratoires Grünenthal","Certification de qualification SGS","la charte de qualité de la visite médicale","certification accrédité","Programme de bourses de recherche","partenariat avec l'EFIC","domaine de la douleur", "recherche pré-clinique", "www.e-g-g.info", "EGG", "Efic Grünenthal Grant", "Harald F. Stock", "CEO", "A propos de nous", "Historique", "Directions", "site en France", "Relation avec associations patients", "Protection de l'environnement", "Information médicale", "Pharmacovigilance", "Domaines thérapeutiques", "Classe pharmacologique", "Plan du site", "Contact", "Mot de passe oublié", "Le groupe Grünenthal", "filiales", "R & D", "la douleur", "recherches innovatrices", "entreprise familiale","Président","Pharmacien Responsable","Michel Fontanille","partenariat avec l'EFIC", "Programme de bourses de recherche", "Efic-Grünenthal-Grant", "ANTAL'J,", "outils de formation médicale", "Zaldiar Effervescent®", "douleurs neuropathiques post-zostériennes", "DPZ", "douleurs modérées à intenses", "douleurs légères à modérées", "états fébriles", "douleurs post-opératoires", "douleurs modérées à sévères", "Composition", "Avis de transparence","Mentions légales","Domaine thérapeutique","Classe pharmacologique", "Indications thérapeutiques", "Nom de marque", "DCI", "Antalgique central et périphérique", "opioïde faible", "douleur modérée à intense", "traitements analgésiques", "nouvelle formulation", "Encyclopédie multimédia", "prix MEDEC", "adresse", "se rendre au siège social", "plan d'accès", "Fax", "Tel.", "Mot de passe oublié", "Direction Générale", "Direction des Ventes", "Direction Commercial Excellence","Direction Marketing", "La Direction Médicale", "Direction des Affaires Réglementaires et Pharmacovigilance", "Direction Administrative et Financière", "Direction des Ressources Humaines", "Ressources Humaines", "Directeur Administratif et Financier","Directeur des Ventes","Directeur Marketing", "Directeur Commercial Excellence", "Directeur Médical", "Directeur Affaires Réglementaires", "Directeur Ressources Humaines", "Directeur Général", "Cyclamed", "Président", "Michel Fontanille","filiale française de Grünenthal GmbH","Dates clés", "Démarche Qualité Douleur","acide tiaprofénique","kétoprofène","tapentadol","NucyntaTM","Euflexxa","paracétamol","codéine","céfotiam hexétil","chlorhydrate de tramadol","Pharmacien Responsable", "Ethique et Responsabilités", "Relation avec associations patients", "Protection de l'environnement", "Historique", "Grünenthal France", "Europe", "Amériques", "Asie", "Australie", "sirop Enfant/Nourrisson", "Code EFPIA","l'Association A.F.V.D.", "l'association Tulipe", "Suppositoire", "comprimé", "Solution Buvable", "Solution Injectable", "Contramal® LP",  "Laboratoires Grünenthal S.A.S.","Offres d'emploi", "Stages", "Candidatures spontanées", "Contact", "candidature", "lettre de motivation", "Témoignages", "carrière", "formation", "Responsable Logistique Achats", "collaborateurs", "métiers", "Finances", "RH", "Marketing", "Médical", "Affaires Réglementaires", "Ventes", "études cliniques", "présence internationale", "l'information médicale", "effets indésirables", "domaines thérapeutiques", "nos médicaments", "service d'information par téléphone", "demande d'information", "pharmacovigilance", "sécurité des patients", "emploi des médicaments", "risques", "bénéfice thérapeutique", "service pharmacovigilance", "pharmacovigilance.fr@grunenthal.com", "Antalgie", "gynécologie", "infectiologie", "inventeurs du tramadol", "prise en charge de la douleur", "échelle numérique", "patient", "échelles d'évaluation de la douleur", "télécharger", "fichier PdF", "PDF", "maladies infectieuses et tropicales", "maladies bactériennes","pneumonies", "ostéites", "méningites", "maladies parasitaires", "paludisme", "toxoplasmose","maladies nosocomiales", "TEXODIL®", "céfotiam héxéti", "céphalosporine de 3ème génération", "sinusites", "angines", "surinfections bronchiques","pneumopathies","ROVAMYCINE®","spiramycine","macrolide de référence",

"infections géales","infections cuées bénigne","pilule contraceptive","BELARA®","contraceptifs oraux modernes","Contraceptifs hormonaux estroprogestatifs","d'Acétate de Chlormadinone","progestatif anti-androgénique","remboursée par la Sécurité Sociale","progestérone naturelle","ethinylestradiol","Antibiotique antibactérien", "Mentions légales", "Clause de non-responsabilité", "Copyright", "Politique de confidentialité", "Protection des données", "Renseignements éditeur", "Équipe editorial", "Plan du site", "Les sites du group", "Notre mission", "La Recherche Clinique", "Recherche et Développement", "AlgiCalm®", "Contramal®", "Lindilane®", "MonoTramal®","Naprosyne®", "Paracétamol 1g", "Surgam®", "Toprec®", "Versatis®", "Zaldiar®", "Zaldiar Effervescent®","Contramal LP","Notice","stimulus douloureux", "douleur pathologique", "l'approche thérapeutique", "douleur aiguë", "douleur chronique", "douleur de longue durée", "brûlures", "les fractures", "les douleurs postopératoires", "douleurs conséquentes à de l'arthrose", "lombalgie", "douleurs nerveuses", "douleurs cancéreuses", "plaintes de douleur"];



var listOfKeywords_cz_CZ = ["Grünenthal Czech s.r.o.", "O nás", "spole

nosti","Produkty spole

nosti","lé

ba bolesti","Kontakty","VeY
ejn
 pY
ístupná odborná informa

ní slu~
ba","VPOIS","dokumento
 VPOIS","indikace","Belara","Ethinylestradiolum a chlormadinoni acetas","PY
íbalové informaci","Versatis","náplast","Lidocainum"];



var listOfKeywords_sl_SI = ["Aachen ", "action medeor", "Change Pain", "Charter of Diversity", "Deutsche Hospiz- Gesellschaft", "EFIC-GRÜNENTHAL Grant", "KCNQ2/3", "Nucynta", "Palexia", "Tamper Resistant Formulation", "Akutna bole

ina", "Analgetiki",  "Uporabe", "artritis bole

ine", "ugodnosti",  "Bradikininov receptor", "kariera",  "Kroni

na bole

ina", "skupni razvoj", "kulturni vplivi", "razvoj", "razvoj analgetikov ", "razvoj bole

ine", "diagnoza", "Odkrijte Grünenthal", "sistemi za doziranje zdravil ", "Donacija Zdravil", "zaposlenega", "okolje", "Izkua
nje", "strokovnjak za bole

ine", "mo~
nosti kariere", "temelj", "brez bole

in", "globalne", "Grünenthal sodelovanje", "Zgodovina", "inovativne", "mednarodnih", "mednarodno podjetje", "zaposlitev", "Bole

ina v kri~
u", "obvladovanje bole

ine", "merjenje bole

ine", "moa
ki bole

ine", "zlorabo", "Nevropatska bole

ina", "novi analgetiki", "Novi sistemi za doziranje zdravil", "opioidne receptorje", "osteoartritis", "bole

ina", "ocena bole

ine", "bole

ine v razvoju", "bole

ine diagnozo", "bole

inam", "bole

inam trg", "bole

inam stranski u

inek", "laja
anje bole

in", "bole

ina merjenje", "bole

ina spomin", "bole

ina stopnja", "bole

ina receptor", "zmanja
anje bole

ine", "laja
anje bole

in", "bole

ina raziskave", "bole

ina lestvice", "bole

ina senzor", "protibole

insko terapijo", "brez bole

in", "paracetamol", "patofiziologija", "izdelkov", "strokovnjakov", "kakovost ~
ivljenja", "R&R  ", "R&R Center", "proces zaposlovanja", "Zahteve", "Raziskave", "hude kroni

ne bole

ine", "kratkoro

nega sistema spodbud ", "dru~
bena odgovornost", "mo

ni opioidi", "uspea
no podjetje", "Spodbujanje nadarjenosti", "tapentadol ", "zdravljenjem akutne bole

ine", "zdravljenje kroni

ne bole

ine", "zdravljenje bole

ine", "tramadol", "Tramal",  "transdermalni obli~
", "Transtec", "Transtec® 35 ¼g/h", "Transtec® 52.5 ¼g/h", "Transtec® 70 ¼g/h", "TRF", "Vaniloidni receptorji", "Napetostno odvisni kalijevi kanali", "Opioidni receptorji", "Versatis", "a
ibki opioidi", "Zaldiar"];



var listOfKeywords_it_IT = ["dolore acuto", "affiliati", "analgesici", "artrite dolore", "recettore della bradichinina", "dolore da cancro", "dolore cronico", "Contramal®", "influenze culturali", "cultura", "sviluppo", "diagnosi", "alla scoperta di Grünenthal", "documentare il dolore", "DOR", "sistemi di formulazione", "a conduzione familiare", "Formenti", "fondazione", "Gruppo Grunenthal", "innovazioni", "innovativo", "azienda innovativa", "internazionale", "azienda internazionale", "lavoro", "KCNQ2/3", "KOLIBRI®", "KOR", "Progetti in fase finale", "LENINERV600", "dolore lombare", "Matrifen®", "misurazione del dolore", "uomini dolore", "MOR", "MOR-NRI", "dolore neuropatico", "nuovi analgesici", "dolore nocicettivo", "non-oppioidi", "nuovi sistemi di formulazione", "NRI", "recettori oppioidi", "ORL1", "osteoartrosi", "dolore", "valutazione del dolore", "dolore diagnosi", "gestione del dolore", "il dolore della memoria", "recettore del dolore", "sollievo dal dolore", "dolore scale", "terapia del dolore", "senza dolore", "paracetamolo", "collaborazioni", "Patch", "fisiopatologia", "paziente con dolore", "farmaceutica", "prodotti", "dolore psicogeno", "R&S", "Il centro di R&D", "ricerca", "influenze sociali", "dolore cronico severo", "dolore somatico", "sponsorizza", "oppioidi forti", "azienda di successo", "Tamper Resistant Formulation", "tapentadol ", "la terapia del dolore acuto", "la terapia del dolore cronico", "terapia del dolore", "tramadol", "cerotto transdermico", "Transtec", "Transtec® 35 ¼g/h", "Transtec® 52.5 ¼g/h", "Transtec® 70 ¼g/h", "trattamento del dolore cronico", "trattamento", "trattamento del dolore acuto", "trattamento del dolore", "TRF", "TRPV1", "tipi di dolore", "valori", "recettori vanilloidi", "scala visiva analogica", "canali del potassio voltaggio-dipendenti", "chi siamo", "donne dolore"];



var listOfKeywords_en_IE = ["Registered Office", "Editor", "Dublin","Family ownership","Analgesia","Expertise","Grünenthal Pharma Ltd.", "Ixprim Effervescent","Versatis","Ixprim","Zydol","Pain management","Chronic pain","Pain therapy","Acute pain","Non-opioid","Paracetamol","Opioid","Tramadol","Moderate pain","Severe pain","Lidocain","Plaster","Herpes zoster infection","Postherpetic neuralgia","Tramadol hydrochloride","Research & Development","Innovative","International","Patients","Healthcare Professionals","Nociceptive pain","Neuropathic pain","European Federation of the International Association of the Study of Pain chapters","EFIC","Values","Vision","Recruitment", "Relationships with Patient Organisations", "Corporate Background", "History", "Vacancies", "Medical enquiries", "Zydol SR", "Product Information", "PIL", "SPC", "Website", "daily dose", "partnership", "Napp","development partners", "R&D expenditures", "Dosage", "Application", "Distribution", "Ordering", "Reporting safety issues", "Reporting quality issues","emergency out of hours", "Recruitment Process", "Application", "Join Grünenthal", "Career"];



var listOfKeywords_sv_SE = ["Aachen","Akut smärta","Anställd","Arbete","Behandling","Behandling av akut smärta","Behandling av kronisk smärta","Bidrag","Change Pain","Dotterbolag","Erfarenhet","Etablerad","Europeiska marknaden","Familjeägt","Forskning","Försäljning","Framgång","Global","Globala produkter","Harald Stock","Harald F. Stock","Historia","Innovation","Innovativa","Internationella","Jobb","Karriär","Karriär hos Grünenthal","Kronisk smärta","Läkemedel","Läkemedelsföretag","Ledande den europeiska marknaden","Livskvalitet","Marknadsföring","Matrixplåstret","Nya smärtstillande medel","Om oss","Partners i smärtlindring","Penicillin","Pipeline","Produkter","Samarbetar","Smärta","Smärtlindring","Smärta Expert","Smärtforskning","Smärtlindrande","Smärtlindrande läkemedel","Smärtlindring","Styrelse","Svår kronisk smärta","Typer av smärta","Universitet","Utbildning","Utveckling","Utveckling av smärta","Utveckling av smärtlindrande läkemedel","VD"];



var listOfKeywords_pt_PT = ["Grünenthal, S.A.", "Vessatis®", "Emplastro medicamentoso de lidocaína", "sistema cutâneo", "lidocaína", "alívio sintomático da dor neuropática", "Zaldiar®", "terapia inovadora", "Galeria de imagens", "Noticias", "Dossier de imprensa", "empresa farmacêutica", "focada no doente", "Recursos Humanos", "Trabalhar", "Vendas", "Principais Áreas terapêuticas", "Euro-Labor,", "benefícios sociais", "Zaldiar® Efe", "RCM", "Comprimidos revestidos", "Comprimidos efervescentes", "Inibidores da MAO", "paracetamol", "nevralgia pós-herpética", "NPH", "herpes zóster", "Hipersensibilidade", "dose habitual", "Tramal® retard", "Comprimidos de libertação prolongada", "Transtec®", "buprenorfina", "sistema transdérmico", "Tratamento da Dor neoplásica", "analgésico opióide", "Opióides fracos", "Opióides potentes", "Buprenorfina sublingual", "Dor moderada a intensa", "Tramal®", "solução injectável", "supositórios", "Gotas orais", "cloridrato de tramadol", "Picalm®", "Picetoprofeno", "Reumatologia", "Traumatologia", "Picalm® creme", "Picalm® aerossole", "Aerossole", "Inalgex®", "Emulsão cutânea", "Dores musculares ligeiras", "Interacções", "Advertências", "Contra-indicações", "Indicações terapêuticas", "Forma Farmacêutica", "Composição", "Oramorph®", "Ampolas unidose", "Ossin®", "Condroitino Sulfato de Sódio", "doença articular degenerativa", "osteoartrose", "dor irruptiva", "Gotas", "Solução", "Sulfato de Morfina", "Inflamação moderada de origem músculo", "Mederma®", "Gel de aplicação tópica", "Hyalart®", "ácido hialurónico", "Artrose dolorosa do joelho", "Resumo das Características do Medicamento", "fitoterapêutico", "Fundação Grünenthal", "Glossário Dor","Profissionais de Saúde", "Great Place to Work", "Empresa", "Sistema Nervoso Central","analgésicos", "produtos", "Famacovigilância",];



var listOfKeywords_es_VE =  ["efecto prolongado", "acetaminofén", "dolor post-operatorio", "lumbalgia", "Reacciones Adversas", "tabletas dispersables", 

"gérmenes susceptibles a la doxiciclina", "depresión respiratoria", "Analgésico de acción central", "Posología", "Composición", "Reacciones Adversas", "Mecanismos de acción", "parche", "Trastornos del sueño", "disturbios nerviosos", "estados de intranquilidad", "aparato de sostén", "golpes", "torceduras", "Etofenamato", "nocturna en el varón adulto", "disuria", "micción imperiosa diurna", "combinación fenazona/lidocaína","fenazona", "antipirina", "oido medio", "anti-inflamatorio", "clorhidrato de lidocaína", "antiséptico", "infecciones del conducto auditivo externo", "Blister", "Sedante nervioso", "Efectos Colaterales", "Ansiolítico", "Alteración del sueño", "Suspensión", "Niños", "actividad antibacteriana", "Adultos","afecciones respiratorias", "Mastopatía fibroquística", "fibromatosis uterina", "carcinoma genital", "carcinoma mamario","bajo costo", "beneficios adicionales", "mujeres ante embarazos", "Anticonceptivo monofásico", "dosificación recomendada", "enfermedad de Ménière", "terapias antivertiginosas","Elixir", "producto natural", "Sin prescripción", "concentración","memoria", "apatía", "fatiga", "debilidad", "agotamiento", "facultades mentales", "Envase calendario", "dolores menstruales", "libido", "peso corporal", "inhalado", "control del asma", "función pulmonar", "Inhalación","organizaciones locales", "Declaración de respeto a la intimidad", "Visión", "Compañía", "historia", "Buprenorfina", "paracetamol", "Lidocaína", "Lornoxicam", "Corteza de Pygeum africanum", "Raíz de Urtica dioica", "Raíz de Lúpulo", "Raíz de Valeriana", "Hoja de Melissa", "Raíz de Panax ginseng", "Hoja de Ginkgo biloba", "Fitoquímica", "Desogestrel", "Anticonceptivo oral", "Etinil Estradiol", "Acetato de clormadinona", "Infectología", "Doxiciclina Monohidrato", "Ciclesonida", "Erdosteína", "Vértigo", "Antivertiginoso","Betahistina diclorhidrato", "portal de Recursos Humanos", "Trabajar en Grünenthal", "Recursos Humanos", "empleados", "Sobredosis", "reacción adversa", "Formulario Embarazo", "Correo electrónico", "Farmacovigilancia", "seguridad de los Pacientes", "unidad de Farmacovigilancia", "Interacciones medicamentosas","receptor 1 de la bradicinina", "epilepsia", "canales de potasio", "KCNQ2/3","receptor vanilloide potencial transitorio 1","RVPT1","investigación", "desarrollo", "I+D", "Respiratorio", "Alvesco®", "Mukial®", "Naturales", "Gincosan®", "Ginsenosan®", "Nervinetas®", "Prostatonin®", "Songha Night®", "Ginecología", "Belara®", "Mipil®", "Mipil®20", "Noal®", "Antivertiginoso","Microser®", "Microser® Forte","Microser® Ultra","Antibióticos","Tremesal®","Grünenthal Venezolana Farmacéutica C.A.","Analgesia Periférica", "Ventajas", "Analgesia Central","Sensibilidad al dolor","Tamper Resistant Formulation","Tipo del dolor","Tipos de dolor","Tipos del analgésicos","Tipos del dolor","Todo sobre el dolor","Trabajar en Grünenthal","Trabajo en Grünenthal","Tramadol", "Tramal Long", "Indicaciones terapéuticas", "Posología y administración", "Ficha técnica", "Dolor crónico","Toperma®","Otirilin","Reugel", "Tratamiento del dolor","Tratamiento del dolor agudo ","Tratamiento del dolor crónico","Tratamiento dolor","Tratamiento migraña","Tratamiento sintomático dolor moderado","Tratar el dolor","TRF","Zaldiar","Zaldiar Efervescente",];